These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8110550)

  • 21. Insulin in the management of the diabetic surgical patient: continuous intravenous infusion vs subcutaneous administration.
    Taitelman U; Reece EA; Bessman AN
    JAMA; 1977 Feb; 237(7):658-60. PubMed ID: 576296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin production rate in normal man as an estimate for calibration of continuous intravenous insulin infusion in insulin-dependent diabetic patients.
    Waldhäusl WK; Bratusch-Marrain PR; Francesconi M; Nowotny P; Kiss A
    Diabetes Care; 1982; 5(1):18-24. PubMed ID: 6754299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-day programmed intraperitoneal insulin delivery in insulin-dependent diabetic man.
    Schade DS; Eaton RP; Friedman NM; Spencer WJ; Standefer JC
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1165-70. PubMed ID: 7014596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery.
    Gustafson PA; Zarro DL; Palanzo DA; Manley NJ; Montesano RM; Quinn M; Elmore BA; Castagna JM
    Perfusion; 2002 Mar; 17(2):141-4. PubMed ID: 11958305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of an artificial beta cell in surgery.
    Horwitz DL; Schwartz SS
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.
    Toft-Nielsen MB; Madsbad S; Holst JJ
    Diabetes Care; 1999 Jul; 22(7):1137-43. PubMed ID: 10388979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.
    Hsia E; Seggelke S; Gibbs J; Hawkins RM; Cohlmia E; Rasouli N; Wang C; Kam I; Draznin B
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3132-7. PubMed ID: 22685233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance of normoglycemia during cardiac surgery.
    Carvalho G; Moore A; Qizilbash B; Lachapelle K; Schricker T
    Anesth Analg; 2004 Aug; 99(2):319-24, table of contents. PubMed ID: 15271698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of acute daytime and nocturnal insulinization on diurnal glucose homeostasis in NIDDM.
    Puhakainen I; Taskinen MR; Yki-Järvinen H
    Diabetes Care; 1994 Aug; 17(8):805-9. PubMed ID: 7956622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of severity of surgery on metabolic control and insulin requirements in insulin-dependent diabetic patients.
    Raucoules-Aimé M; Roussel LJ; Rossi D; Gastaud P; Dolisi C; Grimaud D
    Br J Anaesth; 1995 Feb; 74(2):231-3. PubMed ID: 7696075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study protocol of a randomised controlled trial comparing perioperative intravenous insulin, GIK or GLP-1 treatment in diabetes-PILGRIM trial.
    Polderman JA; Houweling PL; Hollmann MW; DeVries JH; Preckel B; Hermanides J
    BMC Anesthesiol; 2014; 14():91. PubMed ID: 25419179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic control in diabetic subjects following myocardial infarction: difficulties in improving blood glucose levels by intravenous insulin infusion.
    Davies RR; Newton RW; McNeill GP; Fisher BM; Kesson CM; Pearson D
    Scott Med J; 1991 Jun; 36(3):74-6. PubMed ID: 1925506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness of rectal administration of insulin suppository on normal and diabetic subjects.
    Yamasaki Y; Shichiri M; Kawamori R; Kikuchi M; Yagi T; Arai S; Tohdo R; Hakui N; Oji N; Abe H
    Diabetes Care; 1981; 4(4):454-8. PubMed ID: 7049629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
    Polonsky KS; Licinio-Paixao J; Given BD; Pugh W; Rue P; Galloway J; Karrison T; Frank B
    J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The peroperative diabetic: comparison of two methods of giving i.v. insulin].
    Raucoules M; Moisant L; Romagnan MJ; Dolisi C; Velin P; Grimaud D
    Ann Fr Anesth Reanim; 1989; 8 Suppl():R249. PubMed ID: 2690690
    [No Abstract]   [Full Text] [Related]  

  • 36. Peri-operative management of patients with type-2 diabetes mellitus undergoing non-cardiac surgery using liraglutide, glucose-insulin-potassium infusion or intravenous insulin bolus regimens: a randomised controlled trial.
    Polderman JAW; van Steen SCJ; Thiel B; Godfried MB; Houweling PL; Hollmann MW; DeVries JH; Preckel B; Hermanides J
    Anaesthesia; 2018 Mar; 73(3):332-339. PubMed ID: 29230803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-peptide and insulin during blockade of the hyperglycaemic response to surgery by epidural analgesia.
    Brandt MR; Kehlet H; Faber O; Binder Chr
    Clin Endocrinol (Oxf); 1977 Feb; 6(2):167-70. PubMed ID: 844223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients.
    Lazar HL; McDonnell MM; Chipkin S; Fitzgerald C; Bliss C; Cabral H
    Ann Surg; 2011 Sep; 254(3):458-63; discussion 463-4. PubMed ID: 21865944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
    Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
    Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.